tezacaftor
Sign in to saveAlso known as VX-661
Tezacaftor is a medication used for the treatment of cystic fibrosis. It is available in fixed-dose combination medications.
~3 min read
Encyclopedic overview
7 sectionsContents
- Mechanism of action
- Clinical trials
- EVOLVE trial
- History
- Society and culture
- Names
- References
Tezacaftor is a medication used for the treatment of cystic fibrosis. It is available in fixed-dose combination medications.
The combination of tezacaftor with ivacaftor (brand name Symdeko) was approved for medical use in the United States in February 2018, and in Canada in June 2018. As brand name Symkevi it was approved for medical use in the European Union in October 2018.
Excerpted from Wikipedia’s “tezacaftor” article, available under the CC BY-SA 4.0 licence.